TG Therapeutics Inc NKB2.DU Stock
15.85 EUR
{{ price }}
-1.772661%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
15.85
-
15.85 EUR
VOLUME [24H]
300 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
TG Therapeutics Inc Price Chart
TG Therapeutics Inc NKB2.DU Financial and Trading Overview
| TG Therapeutics Inc stock price | 15.85 EUR |
| Previous Close | 24.27 EUR |
| Open | 24.02 EUR |
| Bid | 24.11 EUR x N/A |
| Ask | 24.27 EUR x N/A |
| Day's Range | 24.02 - 24.13 EUR |
| 52 Week Range | 3.47 - 32.14 EUR |
| Volume | 10 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NKB2.DU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
TG Therapeutics Inc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 32.14 EUR |
| 52 Week Low | 3.47 EUR |
| 50-Day Moving Average | 22.89 EUR |
| 200-Day Moving Average | 13.02 EUR |
NKB2.DU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For TG Therapeutics Inc Stock
What is a current NKB2.DU stock price?
TG Therapeutics Inc NKB2.DU stock price today per share is 15.85 EUR.
How to purchase TG Therapeutics Inc stock?
You can buy NKB2.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TG Therapeutics Inc?
The stock symbol or ticker of TG Therapeutics Inc is NKB2.DU.
How many shares does TG Therapeutics Inc have in circulation?
The max supply of TG Therapeutics Inc shares is 0.
What is TG Therapeutics Inc Price to Earnings Ratio (PE Ratio)?
TG Therapeutics Inc PE Ratio is now.
What was TG Therapeutics Inc earnings per share over the trailing 12 months (TTM)?
TG Therapeutics Inc EPS is 0 EUR over the trailing 12 months.